Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis

Classic tumor therapy, consisting of cytotoxic agents and/or targeted therapy, has not overcome therapeutic limitations like poor risk genetic parameters, genetic heterogeneity at different metastatic sites or the problem of undruggable targets. Here we summarize data and trials principally followin...

Full description

Bibliographic Details
Main Authors: Daniel Heudobler, Michael Rechenmacher, Florian Lüke, Martin Vogelhuber, Sebastian Klobuch, Simone Thomas, Tobias Pukrop, Christina Hackl, Wolfgang Herr, Lina Ghibelli, Christopher Gerner, Albrecht Reichle
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Pharmacology
Subjects:
Anakoinosis
communicative reprogramming
transcriptional modulators
metronomic low-dose chemotherapy
glitazones
all-trans retinoic acid
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01357/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.01357/full

Similar Items